ARCHIVES

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975

Remaining DCT Recompetitions

November 7, 1980

NCI RFPs Available. RFAs Available. Program Announcements.

January 14, 2000

Age-adjusted cancer incidence and mortality down slightly, annual report finds.

June 4, 2004

New Prostate Cancer Detection Group to Study Ultrasound

March 6, 1987

Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals

September 7, 1979